Particularly relevant for basal-like breast cancer (BLBC) and BRCA1-associated breast cancers, studies show that ROS levels correlate with the expression and activity of the transcription factor aryl hydrocarbon receptor (AhR). This evidence concerns the gene BRCA1 and breast carcinoma.